Many serious diseases can be caught long before symptoms appear.
Catching them shouldn't require a needle, a clinic, and an appointment.
The world's most powerful home urine test for serious disease (and some wellness too).
The Lab will be available to buy in limited numbers in Spring 2027, offered first to those who register interest
With results in under 5 minutes, early screens for markers of:
Diabetes and pre-diabetes
Kidney disease and impaired kidney function
High blood pressure and cardiovascular disease
Cancers of the bladder and urinary tract
(alongside everyday wellness markers)
Combining advanced science, elegant design and effortless usability, Early is designed to make regular health screening as routine as brushing your teeth.
Step 1: Hold the absorbent tip in your urine stream for 5 seconds, re-cap the test and insert it into your Early Lab
Step 2: Receive results in your Early app within five minutes.
Step 3: Track your trends over time in the app. Early will prompt you to speak to your GP if it identifies a persistent signal worth a closer look.
Lab
A clinical-grade urinalysis system - silent, beautiful and with a 3 month battery life, it measures a panel of biomarkers to laboratory standard accuracy.
Test
Disposable urine test fitted with a tiny electrochemical sensor and patented fluidic technology. Results sent straight to your app in under 5 minutes
With Early, you aren’t just buying a piece of tech. You are entering into a partnership with us. Like all good partnerships, each side has a part to play*
*Your side of the deal:
You pee on the test. That’s actually it
-
Disposable urine test fitted with a tiny electrochemical sensor and patented fluidics technology. These are delivered through your letterbox in line with your chosen delivery schedule and deliver results straight to the app in 5 minutes
-
A clinical-grade miniaturised electrochemical urinalysis system - a fraction of the size and price as the ones in laboratories and hospitals. It’s silent, beautiful, has a 3 month battery life, is waterproof and measures a panel of biomarkers to hospital-standard accuracy and all linked to serious diseases: PH, Potassium, Sodium, Blood in Urine and Glucose, with many more to follow.
Mark Emberton OBE
We need to detect disease at a point when we can still cure it - less invasively and more kindly. That requires looking earlier than our current systems allow. Early is part of that answer”
Mark Emberton OBE
Professor of Interventional Oncology, UCL and former Dean of Medical Sciences, University College London. And Early’s Chief Medical Officer’
Frequently asked
questions
-
Early is developing a clinical-grade urine test you can use at home, built to surface the earliest warning signs of conditions such as urinary tract cancers, diabetes, and heart disease alongside wellness markers. Early is a working lab as much as a company and our scientists are actively working at the forefront of expanding the range of biomarkers we can measure at home. We'll share the full testing profile closer to launch.
-
Because honestly, who likes needles? Or months-long waiting times? Or the 8am scramble to get through to the doctor? Urine sidesteps all of that. It's information-rich, easy to collect, and can be tested privately at home, picking up meaningful changes day to day and surfacing the trends that make early detection possible.
-
Early is designed to plug a gap that, frankly, shouldn’t still exist. Wearables give you plenty of numbers, but not the ones that really matter. Clinical tests get into the detail (once you manage to get one), but only as a fixed snapshot in time. Early is designed for real life: clinical-grade results at home, easy to understand, with trends that build up over time. Built on the conviction that your health is too important to leave to tools that aren't fit for the job.
-
By securing a spot on the waitlist. That’s where pre-release access lives, and where the very first invitations to order will be sent.
-
About as much as a smart watch - with options designed to make regular testing affordable.
-
Spring 2027.